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Abstract
Multipotent somatic stem cells have been identified in various adult tissues. However, the stem/progenitor cells of the
peripheral nerves have been isolated only from fetal tissues. Here, we isolated Schwann-cell precursors/immature Schwann
cells from the injured peripheral nerves of adult mice using a floating culture technique that we call ‘‘Schwann-spheres.’’ The
Schwann-spheres were derived from de-differentiated mature Schwann cells harvested 24 hours to 6 weeks after peripheral
nerve injury. They had extensive self-renewal and differentiation capabilities. They strongly expressed the immature-
Schwann-cell marker p75, and differentiated only into the Schwann-cell lineage. The spheres showed enhanced myelin
formation and neurite growth compared to mature Schwann cells in vitro. Mature Schwann cells have been considered a
promising candidate for cell-transplantation therapies to repair the damaged nervous system, whereas these ‘‘Schwann-
spheres’’ would provide a more potential autologous cell source for such transplantation.
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Introduction
In recent years, multipotent somatic stem cells have been
identified in various adult tissues. In the peripheral nerves, stem/
progenitor cells that are self-renewing and multipotent, with the
potential to differentiate into neurons, glial cells, and myofibro-
blast, have been detected and isolated from fetal [1], but not adult
tissues.
After peripheral nerve injury, mature Schwann cells undergo a
reversion in their molecular phenotype, and come to resemble
those observed in fetal immature nerves [2]. However, no report
has explored how far these cells dedifferentiate, even though
recent progress in understanding neural-crest and Schwann-cell
development has revealed a rather complete picture of glial
development in the early peripheral nerves [3]. In the present
study, we sought to determine whether mature Schwann cells in
adult peripheral nerves that dedifferentiate into stem/progenitor
cells after injury could form spheres in floating culture conditions,
even though such spheres cannot be obtained by culturing the
dissociated cells of intact peripheral nerves from neonates [4] or
adult mice [5].
Here, we cultured the dedifferentiated Schwann cells obtained
from the injured peripheral nerves of adult mice at the specific
time-point under the floating culture condition and isolated
Schwann-cell precursors/immature Schwann cells, as spheres,
which we called ‘‘Schwann-spheres.’’ This is the first report
showing that ‘‘Schwann-spheres’’ can be obtained from adult
peripheral nerves. Moreover, their differentiation, myelination,
and neurite growth promoting properties in vitro suggested their
potential use in cell transplantation therapy for the damaged
nervous system.
Materials and Methods
Animals and surgical procedures
Normal, specific pathogen-free, adult C57BL/6J mice were
purchased from CLEA Japan, Inc., Tokyo, Japan. Nestin-EGFP
transgenic mice carry enhanced green fluorescent protein (EGFP)
under the control of the second intronic enhancer of the nestin
gene, which acts selectively in stem/progenitor cells [6].
Transgenic mice expressing Cre recombinase under control of
the MBP promoter (MBP-Cre)[7] were mated with EGFP reporter
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loxP/loxP-EGFP) [8] to obtain MBP-Cre/Floxed-
CAG-EGFP double-transgenic mice [9].
The adult C57BL/6J mice, Nestin-EGFP mice, and MBP-Cre/
Floxed-CAG-EGFP mice (female, 7-8 weeks old) were anesthe-
tized using an intraperitoneal injection of ketamine (100 mg/kg)
and xylazine (10 mg/kg). The animals were housed in groups
under a 12-hour light/dark cycle, with access to food and water ad
libitum. The sciatic nerve was exposed through a dorsal gluteal
muscle-splitting approach. The nerve was subjected to a contusive
injury at the sciatic notch using a brain aneurysm clip (Sugita clip;
Mizuho Ikakogyo, Tokyo, Japan). The clip was closed and left in
place for 5 min with a holding force of approximately 50 g. All
interventions and animal care procedures were performed in
accordance with the Laboratory Animal Welfare Act, the Guide
for the Care and Use of Laboratory Animals (National Institutes of
Health), and the Guidelines and Policies for Animal Surgery
provided by the Animal Study Committee of Keio University, and
were approved by the Ethics Committee of Keio University.
Sphere-forming cultures
Cells were dissociated from the distal portion of sciatic nerves
before the injury and at 6 or 24 hours, 3, 7, or 10 days, or 2, 3, or
6 weeks after the injury. The cells (1610
5 cells/ml) were
transferred to a sphere-forming floating medium consisting of
DMEM/F-12 (1:1) (Gibco, Carlsbad, CA, USA) supplemented
with insulin (25 mg/ml), transferrin (100 mg/ml), progesterone
(20 nM), sodium selenate (30 nM), putrescine (60 nM) (all from
Sigma-Aldrich, St. Louis, USA), recombinant human EGF
(100 ng/ml) (Pepro Tech, Rocky Hill, NJ, USA), human FGF-
basic (100 ng/ml) (Pepro Tech), B27 (20 ng/ml) (modified from
Nagoshi et al. [10]), and 10% FBS (Equitech-Bio, Kerrville, TX,
USA). By comparison, neural crest stem cells (NCSCs) were
dissociated from the E14.5 dorsal root ganglion (DRG) and neural
stem cells (NSCs) were dissociated from the E14.5 striatum [11].
The NCSCs and NSCs were transferred to the sphere-forming
floating medium without FBS. The cells were cultured in an
incubator at 37uC for 7 days. For clonal sphere expansion, the cells
were cultured in the above medium with 0.8% methylcellulose
(Nacalai Tesque, Kyoto, Japan) [12].
For the secondary sphere formation assays, the 7-day primary
spheres were collected, incubated in 0.25% trypsin-EDTA for
30 min at 37uC, and triturated until a single-cell suspension was
obtained. The cells were centrifuged at 800 rpm for 5 min at 4uC,
and resuspended in the aforementioned sphere culture medium.
The NCSCs and NSCs were resusupended in the sphere culture
medium without FBS.
Characterization of spheres derived from injured
peripheral nerves
Assays using nestin-EGFP and MBP-Cre/Floxed-EGFP
mice. Spheres obtained from the contused sciatic nerves of 7-8-
week-old adult Nestin-EGFP mice and MBP-Cre/Floxed-EGFP
mice were verified by direct EGFP-fluorescent imaging to be
Nestin-positive and derived from MBP-positive cells.
Immunocytochemistry. Spheres were postfixed for 6 hours
in 4% paraformaldehyde (PFA), soaked overnight in 10% sucrose
followed by 30% sucrose, and embedded in cryomolds for
sectioning at 6–8 mm. The spheres were immunostained using
the anti-undifferentiated-cell marker, Nestin (mouse IgG1, 1:200,
BD Pharmingen, San Jose, CA); Schwann-cell markers, P0 (PZO;
chick IgG, 1:200, Aves Labs, Tigard, OR, USA) and p75 (rabbit
IgG, 1:200, Chemicon, Billerica, MA, USA), or the proliferative-
cell marker, PCNA (rabbit IgG, 1:500, Oncogene Research
Product, La Jolla, CA, USA), to define the cell population.
Immunoreactivity was visualized using secondary antibodies
conjugated with Alexa 488 or Alexa 555 (Molecular Probes).
Nuclear counterstaining was performed with Hoechst 33342
(10 mg/ml, Sigma, St. Louis, MO, USA). The samples were
observed with a universal fluorescence microscope (AxioImager
M1; Carl Zeiss, Jena, Germany).
Differentiation analysis. Spheres were plated on poly-L-
lysine (PLL) (Sigma)-coated 8-well chamber slides (Iwaki, Tokyo,
Japan) and cultured for 7 days in the following differentiation
medium: DMEM/F12 (1:1) supplemented with 10% FBS, without
any growth factors [10]. For immunocytochemistry, the cells were
fixed in 4% PFA and stained with the following primary
antibodies: anti-p75 (rabbit IgG, 1:200, Chemicon) and anti-P0
(PZO; chick IgG, 1:200, Aves Labs), to examine their
differentiation into the mature stage of the Schwann-cell lineage.
Secondary antibodies were anti-rabbit IgG (Alexa 488) and anti-
chick IgG (Alexa 568).
The distal portions of intact or injured sciatic nerves (day 7 after
the injury) from MBP-Cre/Floxed-EGFP mice were postfixed for
24 hours in 4% PFA, soaked overnight in 10% sucrose followed by
30% sucrose, and embedded in a cryomold for sectioning at
10 mm. The primary antibodies were anti-GFP (goat IgG, 1:200,
Rockland, Gilbertsville, PA) and anti-p75 (rabbit IgG, 1:200,
Chemicon). The secondary antibodies were anti-goat IgG (Alexa
488) and anti-rabbit IgG (Alexa 555). Nuclear counterstaining was
performed with Hoechst 33342 (10 mg/ml, Sigma). The samples
were observed with a confocal laser scanning microscope
(LSM510, Carl Zeiss).
To examine the tri-lineage differentiation potential, spheres
derived from injured adult sciatic nerves from MBP-Cre/Floxed-
CAG-EGFP mice were plated on PLL-coated 8-well chamber
slides and cultured for 7 days in the above-described differenti-
ation medium. For immunocytochemistry, the cells were fixed in
4% PFA and stained with the following primary antibodies: anti-
GFP (goat IgG, 1:200, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), anti-P0 (PZO; chick IgG, 1:200, Aves Labs), anti-S100
(rabbit IgG, 1:500, Dako, Glostrup, Denmark), anti-b-III tubulin
(mouse IgG2b, 1:500, Sigma), and anti-aSMA (mouse IgG2a,
1:1000, Sigma). Secondary antibodies were the following: anti-
goat IgG (Alexa 488), anti-rabbit IgG (Alexa 555), anti-chick IgG
(Alexa 568), anti-mouse IgG2b (Alexa 488), and anti-mouse IgG2a
(Alexa 647). The samples were observed with a universal
fluorescence microscope (AxioImager M1; Carl Zeiss).
RT-PCR assay. Total RNA was isolated from each sample
with Trizol reagent (Invitrogen, Carlsbad, CA, USA) and DNase I
treatment. Total RNA (1 mg) was used to synthesize cDNA with
oligo-d(T) primers. The cDNA synthesis was performed at 42uC
for 50 min in a final volume of 20 ml, according to the
manufacturer’s instructions for Superscript III reverse
transcriptase (Invitrogen). To normalize the template cDNA, the
ubiquitously expressed b-actin mRNA was used as a reference.
PCR was performed with KOD plus DNA polymerase (Toyobo,
Osaka, Japan) according to the manufacturer’s instructions. The
PCR products were resolved by electrophoresis in 1-3% agarose
gels, and the bands were visualized with ethidium bromide under
UV light [10]. The PCR products were confirmed by sequencing.
The primers are listed in Table 1.
Myelination and neurite-extension assays
DRG neurons were co-cultured with cells derived from intact
sciatic nerves or Schwann-spheres using the modified method of
Hoshikawa et al [13]. The DRGs were taken from adult mice,
dissociated with collagenase and trypsin, and seeded on 8-well
chamber slides coated with poly-L-lysine at 200,000 cells per well.
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seeded onto the DRG cultures in DMEM/F12 medium. The
cocultures were incubated for 2 weeks, and then anti-MBP and
anti-bIII-tubulin antibodies were applied, followed by the
appropriate secondary antibodies. The proportions of MBP-
positive cells (MBP-positive cells/total cells) were counted and
the lengths of the longest bIII-tubulin-positive neurite were
measured in a 0.6 mm
2 field by surveying six fields. The average
was calculated.
Statistical analysis
All values are presented as the mean 6 standard error of the
mean (SEM). Statistical significance was determined as p,0.05
using one-factor ANOVA and the Tukey-Kramer test for the
primary and secondary sphere-forming assays. Student’s t-test was
used to compare the data between groups for the myelination and
neurite outgrowth assays.
Results
Adult injured sciatic nerves include sphere-forming cells
with a high self-renewal capability
To determine whether there were sphere-initiating cells within
adult intact and injured peripheral nerves, we cultured cells derived
from the intact and injured sciatic nerves of adult nestin-EGFP mice
[6]. We succeeded in obtaining spheres from the injured sciatic
nerves in floating culture, when the nerves were harvested at certain
time points after the injury. In contrast, no spheres were obtained
from intact sciatic nerves. These spheres from nestin-EGFP mice
were positive for EGFP, suggesting that they were Nestin-positive
immature cells (Fig. 1A). The distal part of the sciatic nerves
harvested 24 hours to 6 weeks after crush injury, but not at other
time points, could successfully generate spheres in floating culture.
The sphere-forming capacity peaked in the samples derived from
nerves harvested 3 to 10 days after the injury. Quantitative analysis
indicated that approximately 1% of all the viable cells were sphere-
initiating cells during this time (Fig. 1B).
To assess the self-renewing capacity of these spheres, secondary
sphere-forming assays were performed. Primary spheres derived
from sciatic nerves harvested 7 days after injury were dissociated
into single cells and cultured again in the sphere-forming floating
medium. As positive controls, the primary spheres of neural crest
stem cells obtained from fetal DRG and neural stem cells from
fetal striatum were also dissociated and replated to form secondary
spheres. Secondary spheres were successfully obtained from the
dissociated primary sciatic-nerve-derived spheres, although the
sphere-forming rate was lower than the neural crest stem cells and
neural stem cells (Fig. 1C).
To characterize the sphere-forming cells derived from injured
adult sciatic nerves, frozen sections of the spheres were stained
with various cell markers. The spheres were positive for both the
undifferentiated-cell marker Nestin [14] and the proliferative-cell
marker PCNA (Fig. 1D). Interestingly, most of the cells in the
spheres expressed undifferentiated-Schwann-cell marker, p75, and
a small proportion of them were positive for the myelinating-
Schwann-cell marker, P0 (Fig. 1E). These results suggested that
these spheres consisted of Schwann-cell precursors/immature
Schwann cells; we therefore called them, ‘‘Schwann-spheres.’’
Characterization of the Schwann-spheres derived from
adult injured sciatic nerve
ThemajorityofthecellsintheSchwann-spheres werepositivefor
p75, a marker for immature and non-myelinating Schwann cells,
whereasvery few cellswere positiveforP0,a markerformyelinating
Schwann cells (Fig. 2A–a and B–a). We next asked whether the
Schwann-spheres could differentiate into mature Schwann cells in
vitro. After being cultured for 7 days in differentiation medium [10],
approximately 37% of the total cells had differentiated into P0-
positive mature Schwann cells (Fig. 2A–b and B–b), which had a
very similar morphology to the mature Schwann cells derived from
adult intact sciatic nerves (Fig. 2A–c and B–c).
Furthermore,to determinetheoriginoftheSchwann-spheres,we
induced a contusive sciatic nerve injury in MBP-Cre/Floxed-EGFP
mice. In these transgenic mice, transient activation of the MBP
promoter induces Cre-mediated recombination, indelibly tagging
the MBP-positive mature Schwann cells with EGFP expression
[7,8,9]. Double immunostaining for GFP and p75 in frozen sections
of the distal part of the injured sciatic nerves revealed that most of
the GFP-positive cells were positive for p75, whereas very few of the
GFP-positivecellsinintactsciaticnerveswerep75-positive(Fig.3A),
suggesting that myelinating mature Schwann cells could de-
differentiate to the immature stage after peripheral nerve injury.
These EGFP-positivecells could form spheres under floating culture
conditions (Fig. 3B), whereas EGFP-negative cells did not (data not
shown). These findings suggested that the spheres were originally
derived from MBP-positive mature Schwann cells in the pre-injury
sciatic nerves, and that the spheres contained Nestin-positive
immature cells (Fig. 1A). We also examined the trilineage
differentiation potential of the spheres derived from the injured
adult sciatic nerves of MBP-Cre/Floxed-EGFP mice. The EGFP+
spheres derived from these injured adult sciatic nerves differentiated
into glial cells (Fig. 3C), but not into neurons or myofibroblasts (Fig.
S1). These spheres could differentiate only into the Schwann-cell
lineage, suggesting that mature Schwann cells de-differentiate into
Schwann-cell precursors/immature Schwann cells, but not into
neural-crest stem cells after injury.
Table 1. Primer Sequences.
Temp. Size sense antisense
Nestin 60 212 CAGCTGAGCCTATAGTTCAACGC GAAACAAGATCTCAGCAGGCTGAG
Musashi1 60 542 GGCTTCGTCACTTTCATGGACC GGGAACTGGTAGGTGTAACCAG
Pax3 60 171 AACAAGCTGGAGCCAATCAACTG CTGAGGTCTGTGGACGGTGCTA
Sox9 60 263 CACGGAACAGACTCACATCTC TGCTCAGTTCACCGATGTCCA
Sox10 60 134 ACGCACTGAGGACAGCTTTGA ATGAGGTTATTGACACGGAACTGG
p75 60 115 GAGTGCTGCAAAGCCTGCAA TGGCGCTCACCACGTCAGAG
b-actin 60 131 TGACAGGATGCAGAAGGAGA GCTGGAAGGTGGACAGTGAG
doi:10.1371/journal.pone.0021497.t001
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strongly express immature-Schwann-cell markers
Reverse transcription-polymerase chain reaction (RT-PCR)
analysis was conducted to evaluate the mRNA expression of various
stem-cell and Schwann-cell markers in the injured adult sciatic
nerve-derived spheres and fetal neural crest-derived spheres (Fig. 4).
The spheres derived from injured adult sciaticnerves showed higher
expression of the immature-neural-precursor cell markers Nestin and
Musashi-1 than were seen in the intact and injured adult sciatic
nerves. The neural-crest markers Pax3 and Sox9 were also expressed
in the injured adult sciatic nerves and Schwann-spheres. However,
their expression of these genes was lower than that of spheres
derived from fetal sciatic nerves or DRGs. Intact and injured adult
sciatic nerves, fetal sciatic nerves, DRGs, and striatum all expressed
Sox10 as expected, since this gene is expressed at all stages of the
Schwann-cell lineage [15] and is deeply involved in the develop-
ment of the central nervous system [16]. The expression of p75, the
marker of immature and non-myelinating Schwann cells, was
observed in the adult sciatic-nerve-derived Schwann-spheres, as
well in fetal sciatic-nerve- and DRG-derived spheres. Interestingly,
Figure 1. Sphere-forming capacity of cells derived from the injured sciatic nerves of adult mice. (A) Phase-contrast and direct EGFP-
fluorescent images showing the spheres formed from the injured nerves of adult nestin-EGFP mice were EGFP+ after 7 days in floating culture (pre,
pre-injured; 7d, 7 days after injury; Scale bar represents 50 mm). (B) Percentage of sphere-forming cells derived from intact and injured sciatic nerves
at 6 or 24 hours, 3, 7, or 10 days, or 2, 3, or 6 weeks after injury (mean 6 SEM; n=6 per group; x, no spheres observed). While the sciatic nerves
harvested 24 hours to 6 weeks after injury could form spheres under floating culture conditions, those harvested at the other time points did not. (C)
Secondary sphere-forming capability of the spheres derived from adult sciatic nerves compared to those derived from neural-crest stem cells (from
fetal DRGs) and neural stem cells (from fetal striatum). Spheres from injured adult sciatic nerve could be passaged and formed secondary spheres,
indicating their self-renewing ability. One-factor ANOVA and the Tukey-Kramer test were applied (mean 6 SEM; n= per group; *p,0.05). Scale bar
represents 50 mm. (D) The images of immunostained spheres contain Nestin- and PCNA-positive cells. (E) Most of the cells expressed the
undifferentiated Schwann cell marker, p75, whereas few cells were positive for myelinating Schwann cell marker, P0. Scale bar represents 50 mm.
doi:10.1371/journal.pone.0021497.g001
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increased after sphere formation, but decreased in the fetal sciatic
nerve- and DRG-derived spheres.
Schwann-spheres show higher potentials for myelination
and neurite outgrowth than do mature Schwann cells in
vitro
To examine the Schwann-spheres’ therapeutic potential, we
performed myelination and neurite growth assays in vitro [17].
DRG neurons were co-cultured with mature Schwann cells or
with Schwann-spheres derived from injured adult sciatic nerves,
and stained for MBP and bIII-tubulin (Fig. 5A). Both the number
of MBP-positive myelin-forming Schwann cells in myelination
assay [13] (Fig. 5B) and the length of the bIII-tubulin-positive
neuritis in neurite outgrowth assay; [18] (Fig. 5C) were
significantly greater in the co-culture with the Schwann-spheres
derived from injured sciatic nerve compared with the co-culture
with mature Schwann cells derived from intact sciatic nerves.
Thus, the Schwann-spheres enhanced myelin formation and
Figure 2. Differentiation assay of the Schwann-spheres derived from injured adult sciatic nerve. Immunostaining (A) with p75, a marker
for immature and non-myelinating Schwann cells, and P0, a marker for myelinating Schwann cells, and quantitative analysis (B) (a, Sphere from
injured adult sciatic nerves; b, Sphere after differentiation; c, Schwann cells from intact sciatic nerve; mean 6 SEM; n= per group). After inducing their
differentiation, most Schwann-sphere cells differentiated into P0-positive mature Schwann cells, which closely resembled the Schwann cells from
intact sciatic nerves. Scale bar represents 100 mm.
doi:10.1371/journal.pone.0021497.g002
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cells in vitro.
Discussion
This is the first report that Schwann-cell precursors/immature
Schwann cells, in the form of cultured ‘‘Schwann-spheres,’’ can be
isolated from adult peripheral nerves. Mature myelinating and
non-myelinating cells respond to nerve injury by reverting to a
molecular phenotype similar to that of immature Schwann cells, to
provide essential support for axonal regrowth [3]. Therefore, we
hypothesized that undifferentiated spheres could be obtained from
adult injured peripheral nerves. Indeed, here we demonstrated
that adult peripheral nerves harvested at specific time points after
contusive injury could generate de-differentiated spheres under the
floating culture condition with EGF, FGF and fetal bovine serum
(FBS). These Schwann-spheres, which exhibited a high self-
renewal capacity, consisted of Schwann-cell precursors/immature
Schwann cells. Immunocytochemistry and Cre/lox system-medi-
ated lineage tracing analyses showed that the Schwann-spheres
originated from myelinating mature Schwann cells, which de-
differentiated after peripheral nerve injury. In addition, immuno-
histochemical and RT-PCR analyses revealed that the Schwann-
spheres could differentiate into the Schwann-cell lineage, suggest-
ing that mature Schwann cells de-differentiate into Schwann-cell
precursors/immature Schwann cells, but not into neural-crest
stem cells, unlike the spheres derived from fetal sciatic nerves or
DRGs.
Figure 3. Expression pattern of EGFP in the injured sciatic nerves of adult MBP-Cre/Floxed-EGFP mice. (A) Double immunostaining for
GFP and p75 revealed that most of the GFP-positive cells derived from the injured distal sciatic nerves were positive for p75, indicating that the
myelinating mature Schwann cells could de-differentiate to an immature stage after peripheral nerve injury. (B) Phase-contrast and direct EGFP-
fluorescent images showing that the spheres formed from EGFP+ cells after 7 days in floating culture of the injured peripheral nerves from adult MBP-
Cre/Floxed-EGFP mice. (C) Trilineage differentiation potential of the spheres derived from the injured adult sciatic nerves of MBP-Cre/Floxed-EGFP
mice. Double immunocytochemistry revealed that the EGFP+ cells were positive for glial-cell markers, S100 and P0. The EGFP+ spheres derived from
the injured adult sciatic nerves differentiated into glial cells, but not into neurons or myofibroblasts (Fig. S1). Scale bar represents 50 mm.
doi:10.1371/journal.pone.0021497.g003
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transplantation therapies to repair the injured central or
peripheral nervous system [19,20,21]. Previous studies have shown
that Schwann cells promote axonal growth, mainly from sensory
and propriospinal neurons [22]. Moreover, Schwann cells
myelinate the ingrowing axons and re-establish axonal conduction
[23]. Although Schwann-cell transplants have shown only limited
results, in that few long-tract axons enter and few axons exit the
grafts [24], a combination therapy of Schwann cells with
neuroprotective agents, molecules that modify the glial scar
[25,26,27], neurotrophic factors [28,29,30], or camp [31],
enhances the ingrowth of long-descending axons and the exit of
fibers, thereby improving functional recovery. There is a strong
current interest in Schwann-cell-based transplantation strategies
for the treatment of spinal cord injuries [17]. However, several
steps are needed to isolate and obtain highly enriched populations
of mature Schwann cells [32,33]. Moreover, it is difficult to use
mature Schwann cells for regenerative medicine because of their
low proliferative rate and poor survival when grafted into the
injured spinal cord [34,35].
Recently, Agudo et al. reported the novel and potentially useful
properties of an early cell in the Schwann-cell lineage, the
Schwann-cell precursor [36]. Unlike mature Schwann cells,
transplanted Schwann-cell precursors thrive in the spinal cord,
where they survive for a long time. However, Schwann-cell
precursors/immature Schwann cells have not been identified in
adult tissues, and they have not been prospectively isolated from
adult animals, although stem/progenitor cells have been detected
in and isolated from fetal peripheral nerves [1].
In the present study, we also demonstrated that the Schwann-
spheres derived from injured adult sciatic nerves demonstrated
much higher potentials for myelin formation and neurite-growth
enhancement than mature Schwann cells isolated from intact
sciatic nerves in vitro. Skin-derived precursor (SKP)-derived
Schwann cells can myelinate axons [37] and enhance locomotor
recovery better than naive SKPs, when used as a cell-transplan-
tation source after contusion spinal cord injury [36]. Although the
Schwann-spheres differentiated only into the Schwann-cell
lineage, and not into the trilineages of neurons, glial cells, and
myofibroblasts, they provide a more accessible and potential
autologous cell source for transplantation to treat the damaged
peripheral or central nervous system, such as occurs in spinal cord
injury.
Many investigators have studied stem-cell transplantation
therapies for regenerating the central nervous system. Although
the transplantation of fetal neural stem/progenitor cells into the
injured spinal cord can promote functional recovery in adult mice
[38], neonatal rats [39], adult rats [40], and common marmosets
[41], the use of fetal tissue-derived stem cells still generates some
ethical concerns. To regenerate the central nervous system,
multipotent somatic stem cells, which were identified in the adult
skin [36,42] and bone marrow [10], need to differentiate into glial
cells prior to transplantation. In addition, hair follicle stem cells
[43,44] promote repair of peripheral nerve injury [45,46] and
spinal cord injury [47,48]. However, in the results of experiments
using neurospheres derived from pluripotent stem cells (embryonic
stem cells and induced pluripotent stem cells), transplantation of
the gliogenic secondary neurospheres, but not the neurogenic
Figure 4. RT-PCR was conducted to evaluate the mRNA expression of various stem-cell and Schwann-cell markers. The injured adult
sciatic nerve-derived spheres showed a higher expression of the immature-cell markers Nestin and Musashi-1 and neural-crest markers Pax3 and Sox9
than the intact and injured adult sciatic nerves. However, their expression of these genes was lower than that of spheres derived from fetal sciatic
nerves and DRGs. The intact and injured adult sciatic nerves, fetal sciatic nerves, DRGs, and striatum expressed Sox10. The expression of p75 was
observed in the spheres derived from injured adult sciatic nerves, fetal sciatic nerves, and DRGs.
doi:10.1371/journal.pone.0021497.g004
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and angiogenesis after spinal cord injury [49,50]. Also in such stem
cells, to differentiate into glial cells prior to transplantation might
be effective for promoting the recovery from spinal cord injury.
Interestingly, Widera et al. very recently reported obtaining
spheres from the intact sciatic nerve under serum-free medium
[51], while we reported observing sphere formation only from the
injured nerve under the medium including serum. The former
showed that sphere cells were able to differentiate into ectodermal,
mesodermal and endodermal cells, while the latter showed that the
spheres were able to differentiate only into glial cells. This
discrepancy could be partly because of the differences in the
culture conditions. In addition, in agreement with the results of
others [4,5], we could not identify nestin-positive cells and spheres
in our culture conditions from intact nerves, although we obtained
them from injured nerves. Although the spheres that the former
reported are more interesting from the biological standpoint,
gliogenic spheres such as the spheres in our report might be more
effective for the cell transplantation therapies in the same reason.
Recently, induced pluripotent stem cells (iPS cells) [52] were
recognized as a possible donor source for transplantation therapy,
because of their high pluripotency and potential for proliferation.
However, a major concern associated with iPS cell-based therapies
is tumor formation [53,54], which is correlated with the
persistence of undifferentiated cells that remain after differentia-
tion is induced. In contrast, Schwann-spheres, which contain
Schwann-cell precursors/immature Schwann cells, but not neural
crest stem cells, mostly differentiate into mature Schwann cells
without any specific induction protocol. Taken together, our
findings indicate that Schwann-spheres could be a novel candidate
Figure 5. Myelination and neurite-growth assays. DRG neurons were co-cultured with mature Schwann cells from intact sciatic nerves or with
Schwann-spheres derived from sciatic nerves harvested 1 week after injury. The cells were then double-stained for MBP and bIII-tubulin (A). The
proportion of MBP-positive cells (MBP-positive cells/total cells) (B, myelination assay) and length of the longest bIII-tubulin-positive neurites (C,
neurite outgrowth assay) in a 0.6-mm
2 field were measured. Schwann-spheres caused enhanced myelination and neurite outgrowth compared with
mature Schwann cells derived from intact sciatic nerves. Student’s t-test was used to compare the data between groups (mean 6 SEM; n= per group;
*, p,0.05; **, p,0.01). Scale bar represents 50 mm.
doi:10.1371/journal.pone.0021497.g005
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Supporting Information
Figure S1 Trilineage differentiation potential of the spheres
derived from the injured adult sciatic nerves of MBP-Cre/Floxed-
EGFP mice. EGFP+ spheres derived from the injured adult sciatic
nerves differentiated into glial cells (Fig. 3C), but not into neurons
or myofibroblasts. Glial-cell markers, S100, p75, and P0; neuronal
markers, NeuN and Hu; myofibroblast marker, SMA. bIII tubulin
and peripherin can label peripheral glia in culture, although they
are also known as neuronal markers. Scale bar, 50 mm.
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